Salomon & Ludwin
IART icon

Salomon & Ludwin’s Integra LifeSciences IART Stock Holding History

Salomon & Ludwin’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32K Hold
1,965
– – ﹤0.01% 671
2026
Q2 		$35.2K Sell
1,965
-768
-28% -$10.7K ﹤0.01% 741
2026
Q1 		$26K Buy
2,733
+2,480
+980% +$27.2K ﹤0.01% 896
2025
Q4 		$3.18K Sell
253
-351
-58% -$4.67K ﹤0.01% 1921
2025
Q3 		$8.94K Buy
+604
New +$8.27K ﹤0.01% 1396

Other funds holding IART

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Paradigm Capital Management Inc
Paradigm Capital Management Inc Albany, New York $3.17B AUM 63.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Salomon & Ludwin's IART Position: Q3 2026 in Review

Salomon & Ludwin held its Integra LifeSciences (IART) position steady in Q3 2026 at 1,965 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Salomon & Ludwin first reported a position in IART in Q3 2025 and has held it in 5 quarters since. The position peaked at $35.2K in Q2 2026. 179 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Salomon & Ludwin held 1,965 shares of Integra LifeSciences worth $32K as of Q3 2026.
  • Salomon & Ludwin left its Integra LifeSciences share count unchanged in Q3 2026.
  • Integra LifeSciences made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #671 holding.
  • Salomon & Ludwin first reported a position in Integra LifeSciences in Q3 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's Integra LifeSciences position peaked at $35.2K in Q2 2026.
  • 179 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.